Showing 121 - 140 results of 100,572 for search '(( 5 ht decrease ) OR ( 5 ((((mg decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.40s Refine Results
  1. 121
  2. 122
  3. 123

    Gene expression of 5-HT transporter (5-HTT), 5-HT<sub>1A</sub> receptor (5-HT<sub>1A</sub>R) and tryptophan hydroxylase-2 (TPH2) in the raphe. by Thibault Renoir (348572)

    Published 2013
    “…<p>Measuring mRNA levels of several genes encoding proteins that regulate 5-HT homeostasis, we found significant genotype-sex interactions for both mRNA levels of (A) 5-HTT and (B) TPH2 but not for (C) 5-HT<sub>1A</sub>R gene expression. …”
  4. 124
  5. 125
  6. 126
  7. 127

    Expression of 5-HT<sub>4(b)</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub> and 5-HTT mRNA in left ventricular myocardium. by Trond Brattelid (290970)

    Published 2013
    “…(A) 5-HT<sub>4(b)</sub> mRNA levels decreased with foetal and neonatal development and the level in adult myocardium was one tenth of that at day -3 but reappeared in HF; (B) 5-HT<sub>2A</sub> mRNA expression increased at birth (day 1), decreased during neonatal development and was unaltered in HF; (C) 5-HT<sub>2B</sub> mRNA expression was transiently increased at birth (day 1) compared to adult (day 113) and not changed in HF; (D) 5-HTT mRNA expression was lower in foetal hearts compared to neonatal, adult, Sham and HF which all showed a similar expression level. …”
  8. 128

    Ageing results in an abrupt decrease in overall neurogenesis in the mouse DG. by Joana Gil-Mohapel (462002)

    Published 2013
    “…(C) An estimation of overall neurogenesis based on the total number of BrdU-positive cells that survived the 42-day period multiplied by the proportion of BrdU-positive cells that acquired a mature neuronal phenotype indicates an age-induced significant and abrupt decrease in the overall number of new neurons. *** <i>p</i> < 0.001 between 1.5 and 3 months and between 3 and 6 months. …”
  9. 129

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  10. 130

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  11. 131
  12. 132
  13. 133

    Acute JMV2959 treatment decreases alcohol preference in rats. by Petra Suchankova (400313)

    Published 2013
    “…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”
  14. 134

    Acute JMV2959 treatment decreases alcohol intake in rats. by Petra Suchankova (400313)

    Published 2013
    “…<p>(A) The acute effects of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) administration on alcohol intake was evaluated at 1 hour time interval after both two and five months of voluntary alcohol consumption. …”
  15. 135
  16. 136

    Damage accumulation decreases elongation rates and displaces growth equilibrium. by Audrey Menegaz Proenca (845486)

    Published 2019
    “…<p>All panels depict MG1655 wild-type <i>E</i>. <i>coli</i>. (A) Exposure to phototoxic damage led to decreasing elongation rates in all treatment levels (length of exposure, every 2 min: 70 ms, 700 ms, 1 s, 1.5 s, 3 s). …”
  17. 137
  18. 138
  19. 139
  20. 140